Evgenii Belykh1, Eric J Miller2, Danying Hu3, Nikolay L Martirosyan2, Eric C Woolf4, Adrienne C Scheck5, Vadim A Byvaltsev6, Peter Nakaji2, Leonard Y Nelson7, Eric J Seibel7, Mark C Preul8. 1. Department of Neurosurgery, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, Arizona, USA; Department of Neurosurgery, Irkutsk State Medical University, Irkutsk, Russia. 2. Department of Neurosurgery, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, Arizona, USA. 3. Biorobotics Laboratory, Department of Electrical Engineering, University of Washington, Seattle, Washington, USA. 4. Department of Neuro-Oncology Research, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, Arizona, USA. 5. Department of Neurosurgery, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, Arizona, USA; Department of Neuro-Oncology Research, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, Arizona, USA. 6. Department of Neurosurgery, Irkutsk State Medical University, Irkutsk, Russia. 7. Human Photonics Laboratory, Department of Mechanical Engineering, University of Washington, Seattle, Washington, USA. 8. Department of Neurosurgery, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, Arizona, USA. Electronic address: Neuropub@barrowneuro.org.
Abstract
OBJECTIVE: Fluorescence-guided surgery with protoporphyrin IX (PpIX) as a photodiagnostic marker is gaining acceptance for resection of malignant gliomas. Current wide-field imaging technologies do not have sufficient sensitivity to detect low PpIX concentrations. We evaluated a scanning fiber endoscope (SFE) for detection of PpIX fluorescence in gliomas and compared it to an operating microscope (OPMI) equipped with a fluorescence module and to a benchtop confocal laser scanning microscope (CLSM). METHODS: 5-Aminolevulinic acid-induced PpIX fluorescence was assessed in GL261-Luc2 cells in vitro and in vivo after implantation in mouse brains, at an invading glioma growth stage, simulating residual tumor. Intraoperative fluorescence of high and low PpIX concentrations in normal brain and tumor regions with SFE, OPMI, CLSM, and histopathology were compared. RESULTS: SFE imaging of PpIX correlated to CLSM at the cellular level. PpIX accumulated in normal brain cells but significantly less than in glioma cells. SFE was more sensitive to accumulated PpIX in fluorescent brain areas than OPMI (P < 0.01) and dramatically increased imaging time (>6×) before tumor-to-background contrast was diminished because of photobleaching. CONCLUSIONS: SFE provides new endoscopic capabilities to view PpIX-fluorescing tumor regions at cellular resolution. SFE may allow accurate imaging of 5-aminolevulinic acid labeling of gliomas and other tumor types when current detection techniques have failed to provide reliable visualization. SFE was significantly more sensitive than OPMI to low PpIX concentrations, which is relevant to identifying the leading edge or metastasizing cells of malignant glioma or to treating low-grade gliomas. This new application has the potential to benefit surgical outcomes.
OBJECTIVE: Fluorescence-guided surgery with protoporphyrin IX (PpIX) as a photodiagnostic marker is gaining acceptance for resection of malignant gliomas. Current wide-field imaging technologies do not have sufficient sensitivity to detect low PpIX concentrations. We evaluated a scanning fiber endoscope (SFE) for detection of PpIX fluorescence in gliomas and compared it to an operating microscope (OPMI) equipped with a fluorescence module and to a benchtop confocal laser scanning microscope (CLSM). METHODS:5-Aminolevulinic acid-induced PpIX fluorescence was assessed in GL261-Luc2 cells in vitro and in vivo after implantation in mouse brains, at an invading glioma growth stage, simulating residual tumor. Intraoperative fluorescence of high and low PpIX concentrations in normal brain and tumor regions with SFE, OPMI, CLSM, and histopathology were compared. RESULTS: SFE imaging of PpIX correlated to CLSM at the cellular level. PpIX accumulated in normal brain cells but significantly less than in glioma cells. SFE was more sensitive to accumulated PpIX in fluorescent brain areas than OPMI (P < 0.01) and dramatically increased imaging time (>6×) before tumor-to-background contrast was diminished because of photobleaching. CONCLUSIONS: SFE provides new endoscopic capabilities to view PpIX-fluorescing tumor regions at cellular resolution. SFE may allow accurate imaging of 5-aminolevulinic acid labeling of gliomas and other tumor types when current detection techniques have failed to provide reliable visualization. SFE was significantly more sensitive than OPMI to low PpIX concentrations, which is relevant to identifying the leading edge or metastasizing cells of malignant glioma or to treating low-grade gliomas. This new application has the potential to benefit surgical outcomes.
Authors: Daphne Meza; Danni Wang; Yu Wang; Sabine Borwege; Nader Sanai; Jonathan T C Liu Journal: Lasers Surg Med Date: 2015-04-14 Impact factor: 4.025
Authors: Nikolay L Martirosyan; Joseph Georges; Jennifer M Eschbacher; Daniel D Cavalcanti; Ali M Elhadi; Mohammed G Abdelwahab; Adrienne C Scheck; Peter Nakaji; Robert F Spetzler; Mark C Preul Journal: Neurosurg Focus Date: 2014-02 Impact factor: 4.047
Authors: Christian Ewelt; Frank W Floeth; Jörg Felsberg; Hans J Steiger; Michael Sabel; Karl-Josef Langen; Gabriele Stoffels; Walter Stummer Journal: Clin Neurol Neurosurg Date: 2011-04-20 Impact factor: 1.876
Authors: Mohammed Jaber; Johannes Wölfer; Christian Ewelt; Markus Holling; Martin Hasselblatt; Thomas Niederstadt; Tarek Zoubi; Matthias Weckesser; Walter Stummer Journal: Neurosurgery Date: 2016-03 Impact factor: 4.654
Authors: Evgenii Belykh; Arpan A Patel; Eric J Miller; Baran Bozkurt; Kaan Yağmurlu; Eric C Woolf; Adrienne C Scheck; Jennifer M Eschbacher; Peter Nakaji; Mark C Preul Journal: Cancer Manag Res Date: 2018-08-30 Impact factor: 3.989
Authors: Evgenii Belykh; Eric J Miller; Arpan A Patel; Baran Bozkurt; Kaan Yağmurlu; Timothy R Robinson; Peter Nakaji; Robert F Spetzler; Michael T Lawton; Leonard Y Nelson; Eric J Seibel; Mark C Preul Journal: Sci Rep Date: 2018-08-22 Impact factor: 4.379
Authors: Vadim A Byvaltsev; Liudmila A Bardonova; Naomi R Onaka; Roman A Polkin; Sergey V Ochkal; Valerij V Shepelev; Marat A Aliyev; Alexander A Potapov Journal: Front Oncol Date: 2019-09-24 Impact factor: 6.244
Authors: Yuan Xu; Irakliy Abramov; Evgenii Belykh; Giancarlo Mignucci-Jiménez; Marian T Park; Jennifer M Eschbacher; Mark C Preul Journal: Front Oncol Date: 2022-08-24 Impact factor: 5.738
Authors: Michael Reinert; Deborah Piffaretti; Marco Wilzbach; Christian Hauger; Roland Guckler; Francesco Marchi; Maria Luisa D'Angelo Journal: Front Surg Date: 2019-07-16